Ameriprise
AKYA

Ameriprise’s Akoya BioSciences AKYA Stock Holding History

Ameriprise’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,300
Closed -$41.6K – 4074
2024
Q3 		$41.6K Sell
15,300
-4,400
-22% -$10.7K ﹤0.01% 3890
2024
Q2 		$46.1K Sell
19,700
-15,150
-43% -$48.3K ﹤0.01% 3820
2024
Q1 		$163K Sell
34,850
-5,175
-13% -$26.9K ﹤0.01% 3715
2023
Q4 		$195K Sell
40,025
-5,300
-12% -$22K ﹤0.01% 3729
2023
Q3 		$211K Buy
45,325
+20,175
+80% +$116K ﹤0.01% 3688
2023
Q2 		$186K Sell
25,150
-1,007
-4% -$6.72K ﹤0.01% 3742
2023
Q1 		$214K Sell
26,157
-14,750
-36% -$154K ﹤0.01% 3714
2022
Q4 		$391K Hold
40,907
– – ﹤0.01% 3495
2022
Q3 		$480K Sell
40,907
-6,927
-14% -$91.3K ﹤0.01% 3408
2022
Q2 		$614K Sell
47,834
-48,378
-50% -$501K ﹤0.01% 3323
2022
Q1 		$1.06M Sell
96,212
-595
-0.6% -$6.9K ﹤0.01% 3194
2021
Q4 		$1.48M Buy
96,807
+51,310
+113% +$671K ﹤0.01% 3078
2021
Q3 		$635K Buy
45,497
+3,705
+9% +$61.9K ﹤0.01% 3324
2021
Q2 		$808K Buy
+41,792
New +$863K ﹤0.01% 3305

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Ameriprise's AKYA Position: Q4 2024 in Review

Ameriprise sold out of Akoya BioSciences (AKYA) in Q4 2024, closing a stake of 15,300 shares — an estimated $41.6K sold.

Ameriprise first reported a position in AKYA in Q2 2021 and held it in 14 quarters. The position peaked at $1.48M in Q4 2021. 61 funds tracked by Wall St. Rank hold AKYA as of Q4 2024.

  • Ameriprise reported no remaining Akoya BioSciences position as of Q4 2024 after selling out during the quarter.
  • Ameriprise sold 15,300 Akoya BioSciences shares in Q4 2024, an estimated $41.6K.
  • Ameriprise first reported a position in Akoya BioSciences in Q2 2021 and held it in 14 quarters.
  • Ameriprise's Akoya BioSciences position peaked at $1.48M in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Akoya BioSciences as of Q4 2024.

Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.